Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Guan, Junjie ^a   Zhang, Jieyuan ^a   Zhu, Zhenzhong ^a   Niu, Xin ^a   Guo, Shangchun ^a   Wang, Yang ^a   Zhang, Changqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; LENTIVIRUS VECTOR; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STEM CELL TRANSPLANTATION; URINE DERIVED STEM CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION; URINE;

LENTIVIRUS; MUS MUSCULUS;

ADULT; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENETIC VECTORS; HUMANS; LENTIVIRUS; MALE; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; OSTEOCALCIN; OSTEOGENESIS; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; STEM CELLS; URINE;

EID: 84928732887     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt539     Document Type: Article

References (27)

1. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, et al.: Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008, 180:2226-33. 10.1016/j.juro.2008.07.023
2. Guan J, Niu X, Gong F, Hu B, Guo S, Lou Y, et al.: Biological characteristics of human urine derived stem cells: potential for cell-based therapy in neurology. Tissue Eng Part A. 2014, 6:6.
3. Bodin A, Bharadwaj S, Wu S, Gatenholm P, Atala A, Zhang Y: Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials. 2010, 31:8889-901. 10.1016/j.biomaterials.2010.07.108
4. Wu S, Liu Y, Bharadwaj S, Atala A, Zhang Y: Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials. 2011, 32:1317-26. 10.1016/j.biomaterials.2010.10.006
5. Bishop GB, Einhorn TA: Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop. 2007, 31:721-7. 10.1007/s00264-007-0424-8
6. Haidar ZS, Hamdy RC, Tabrizian M: Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009, 31:1817-24. 10.1007/s10529-009-0099-x
7. Hsu WK, Sugiyama O, Park SH, Conduah A, Feeley BT, Liu NQ, et al.: Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone. 2007, 40:931-8. 10.1016/j.bone.2006.10.030
8. Dragoo JL, Lieberman JR, Lee RS, Deugarte DA, Lee Y, Zuk PA, et al.: Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg. 2005, 115:1665-73. 10.1097/01.PRS.0000161459.90856.AB
9. Wright V, Peng H, Usas A, Young B, Gearhart B, Cummins J, et al.: BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther. 2002, 6:169-78. 10.1006/mthe.2002.0654
10. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K, et al.: Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther. 2003, 7:354-65. 10.1016/S1525-0016(02)00062-X
11. Zou D, Zhang Z, Ye D, Tang A, Deng L, Han W, et al.: Repair of critical-sized rat calvarial defects using genetically engineered bone marrow-derived mesenchymal stem cells overexpressing hypoxia-inducible factor-1alpha. Stem Cells. 2011, 29:1380-90.
12. Sugiyama O, An DS, Kung SP, Feeley BT, Gamradt S, Liu NQ, et al.: Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther. 2005, 11:390-8.
13. van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, et al.: The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol in Vitro. 2004, 18:1-12. 10.1016/j.tiv.2003.08.009
14. Wessman SJ, Levings RL: Benefits and risks due to animal serum used in cell culture production. Dev Biol Stand. 1999, 99:3-8.
15. van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, Knudsen LE, et al.: Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro. 2010, 24:1053-63. 10.1016/j.tiv.2010.03.016
16. Gao X, Usas A, Lu A, Tang Y, Wang B, Chen CW, et al.: BMP2 is superior to BMP4 for promoting human muscle-derived stem cell-mediated bone regeneration in a critical-sized calvarial defect model. Cell Transplant. 2013, 22:2393-408. 10.3727/096368912X658854
17. Musgrave DS, Pruchnic R, Wright V, Bosch P, Ghivizzani SC, Robbins PD, et al.: The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone. 2001, 28:499-506. 10.1016/S8756-3282(01)00413-6
18. Hosseinkhani H, Yamamoto M, Inatsugu Y, Hiraoka Y, Inoue S, Shimokawa H, et al.: Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. Biomaterials. 2006, 27:1387-98. 10.1016/j.biomaterials.2005.08.017
19. Kim S, Jeon O, Lee J, Bae M, Chun HJ, Moon SH, et al.: Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. J Biomed Sci. 2008, 15:771-7. 10.1007/s11373-008-9277-4
20. Quintavalla J, Uziel-Fusi S, Yin J, Boehnlein E, Pastor G, Blancuzzi V, et al.: Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials. 2002, 23:109-19. 10.1016/S0142-9612(01)00086-2
21. Hasegawa N, Kawaguchi H, Hirachi A, Takeda K, Mizuno N, Nishimura M, et al.: Behavior of transplanted bone marrow-derived mesenchymal stem cells in periodontal defects. J Periodontol. 2006, 77:1003-7. 10.1902/jop.2006.050341
22. Betz VM, Betz OB, Harris MB, Vrahas MS, Evans CH: Bone tissue engineering and repair by gene therapy. Front Biosci. 2008, 13:833-41. 10.2741/2724
23. Giacca M, Zacchigna S: Virus-mediated gene delivery for human gene therapy. J Control Release. 2012, 161:377-88. 10.1016/j.jconrel.2012.04.008
24. Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, et al.: Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther. 2007, 15:1947-54. 10.1038/sj.mt.6300281
25. Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, et al.: Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 2014, 383:1138-46. 10.1016/S0140-6736(13)61939-X
26. Picanco-Castro V, de Sousa Russo-Carbolante EM, Tadeu CD: Advances in lentiviral vectors: a patent review. Recent Pat DNA Gene Seq. 2012, 6:82-90. 10.2174/187221512801327433
27. Pluta K, Kacprzak MM: Use of HIV as a gene transfer vector. Acta Biochim Pol. 2009, 56:531-95.